Multi-Variant Risk Reporting in the Coriell Personalized Medicine Collaborative (CPMC®) Research Study Section 1: Background, Purpose, and Executive Summary Background and Purpose On May 9, 2013 the Coriell Personalized

First Page		Document Content
Date: 2014-03-07 14:04:32 Risk management Population genetics Classical genetics Medical informatics Relative risk Hardy–Weinberg principle Personalized medicine Genotype Risk Biology Genetics Statistics		Multi-Variant Risk Reporting in the Coriell Personalized Medicine Collaborative (CPMC®) Research Study Section 1: Background, Purpose, and Executive Summary Background and Purpose On May 9, 2013 the Coriell Personalized Add to Reading List Source URL: cpmc1.coriell.org Download Document from Source Website File Size: 585,38 KB Share Document on Facebook

	DOCX Document DocID: 1vDmU - View Document
	Personalized Medicine & Diagnostics Track DocID: 1voQg - View Document
	Microsoft Word - Personalized_Medicine_101_fact-sheet.docx DocID: 1vitW - View Document
	Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine. Stefano Cairo1, Aurore Gorse1, Delphine Nicolle1, Erwan Selingue1, DocID: 1vh8d - View Document
	FOR IMMEDIATE RELEASE Contact: Joanne WestphalPhRMA Foundation 2018 Value Assessment Challenge Awards to Focus on Personalized Medicine More than $80,000 in funding to support research t DocID: 1vdt9 - View Document